Healthpeak Properties
DOC
18.66
-0.34
-1.79%
Healthpeak Properties
US · DOC
#1197 by market cap
Listed 1970
18.66
-0.34
-1.79%
Live - 5344 symbols - heartbeat 490s ago
· 2026-10-08 07:27
Pre-market
18.58
-0.43%
After-hours
18.66
0.00%
Overnight
18.73
+0.38%
- Market cap
- 12.87B
- P/E (TTM)i
- 53.31
- P/Bi
- 1.64
- EPSi
- 0.10
- Div yieldi
- 6.54%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on DOC?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Latest year +4.52% YoY
Margins
- Gross margin
- 60.00%
- Operating margin
- 19.28%
- Net margin
- 2.50%
Key ratios & quality
- Enterprise valuei
- 22.25B
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.24B | 1.64B | 1.90B | 2.06B | 2.18B | 2.70B | 2.82B |
| Gross profit | 812.66M | 835.10M | 862.33M | 1.12B | 1.20B | 1.28B | 1.63B | 1.69B |
| Selling & admin expenses | 96.70M | 92.97M | 93.24M | 98.30M | 131.03M | 95.13M | 97.16M | 90.42M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 311.28M | 306.94M | 215.15M | 340.32M | 356.59M | 433.91M | 471.22M | 544.13M |
| Pretax profit | 838.58M | 176.32M | 217.68M | 128.37M | 507.13M | 314.94M | 273.17M | 284.29M |
| Tax | -4.40M | -5.48M | -9.42M | -3.26M | -4.43M | -9.62M | 4.35M | 9.28M |
| Net profit | 1.07B | 60.06M | 428.25M | 525.93M | 516.42M | 334.76M | 267.30M | 101.03M |
| Basic EPS | 2 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Diluted EPS | 2.24 | 0.09 | 0.77 | 0.93 | 0.92 | 0.56 | 0.36 | 0.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 702.89M | 694.35M | 705.87M | 719.40M | 752.95M | 771.58M |
| Gross profit | 429.75M | 418.17M | 413.95M | 431.55M | 429.09M | 438.46M |
| Selling & admin expenses | 26.12M | 20.76M | 19.91M | 23.63M | 24.59M | 22.52M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 135.08M | 131.49M | 131.73M | 145.84M | 114.77M | 132.55M |
| Pretax profit | 54.29M | 39.65M | 65.24M | 125.11M | 195.65M | 59.33M |
| Tax | 2.08M | 2.38M | -1.21M | 6.03M | 254.00K | -1.40M |
| Net profit | 50.06M | 39.02M | -109.85M | 121.79M | 199.66M | 63.24M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.06 | 0.05 | -0.17 | 0.16 | 0.28 | 0.08 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 359.10M | 3.98B | 2.98B | 713.43M | 604.97M | 561.28M | 924.87M | 1.30B |
| Cash & ST investments | 110.79M | 80.40M | 44.23M | 158.29M | 72.03M | 117.64M | 119.82M | 467.46M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 12.72B | 14.03B | 15.92B | 15.26B | 15.77B | 15.70B | 19.94B | 20.34B |
| Total current liabilities | 472.81M | 954.22M | 1.31B | 1.94B | 1.77B | 1.38B | 875.34M | 1.81B |
| Short-term debt | 80.10M | 93.00M | 129.59M | 1.17B | 995.61M | 720.00M | 150.00M | 1.08B |
| Long-term debt | 5.49B | 5.91B | 6.17B | 5.00B | 5.50B | 6.16B | 8.57B | 8.77B |
| Total liabilities | 6,205,962,000.00 | 7,365,417,000.00 | 8,572,743,000.00 | 8,111,415,000.00 | 8,482,952,000.00 | 8,773,980,000.00 | 10,880,631,000.00 | 12,033,567,000.00 |
| Total equity | 6.51B | 6.67B | 7.35B | 7.15B | 7.29B | 6.92B | 9.06B | 8.30B |
| Retained earnings | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 913.88M | 994.27M | 981.67M | 1.30B | 2.03B | 2.09B |
| Cash & ST investments | 70.63M | 89.44M | 91.04M | 467.46M | 1.17B | 1.63B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 19.82B | 19.81B | 19.58B | 20.34B | 21.62B | 21.68B |
| Total current liabilities | 834.22M | 1.51B | 1.13B | 1.81B | 2.42B | 2.18B |
| Short-term debt | 164.00M | 775.00M | 368.13M | 1.08B | 1.75B | 1.50B |
| Long-term debt | 8.71B | 8.27B | 8.76B | 8.77B | 8.67B | 8.54B |
| Total liabilities | 10,972,320,000.00 | 11,223,326,000.00 | 11,317,097,000.00 | 12,033,567,000.00 | 12,556,212,000.00 | 12,181,606,000.00 |
| Total equity | 8.84B | 8.59B | 8.27B | 8.30B | 9.06B | 9.50B |
| Retained earnings | -- | -- | -- | -- | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 848.71M | 846.07M | 758.43M | 795.25M | 900.26M | 956.24M | 1.07B | 1.25B |
| Depreciation & amortization | 549.50M | 659.99M | 697.14M | 684.29M | 710.57M | 724.11M | 1.03B | 1.02B |
| Free cash flow | 848.71M | 846.07M | 758.43M | 795.25M | 900.26M | 956.24M | 1.07B | 1.25B |
| Dividends paid | -696.91M | -720.12M | -787.07M | -650.08M | -648.05M | -657.02M | -794.78M | -849.10M |
| Stock buybacks / issuance | 214.22M | 790.54M | 1.06B | -7.81M | 240.26M | -6.25M | -190.37M | -96.00M |
| Ending cash balance | 61.15M | 184.66M | 181.69M | 219.45M | 126.83M | 169.02M | 184.31M | 537.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 279.43M | 363.49M | 314.96M | 294.08M | 260.88M | 361.10M |
| Depreciation & amortization | 258.33M | 276.13M | 262.32M | 225.34M | 283.14M | 289.99M |
| Free cash flow | 279.43M | 363.49M | 314.96M | 294.08M | 260.88M | 361.10M |
| Dividends paid | -213.48M | -211.88M | -211.87M | -211.86M | -211.99M | -210.26M |
| Stock buybacks / issuance | -24.90M | -71.98M | 116.00K | 755.00K | 900.05M | 591.65M |
| Ending cash balance | 138.61M | 163.28M | 159.73M | 537.70M | 1.27B | 1.72B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.82 | 0.73 | 6.39 | 7.55 | 7.56 | 4.68 | 3.29 | 0.89 |
| ROA %i | 7.90 | 0.33 | 2.75 | 3.22 | 3.21 | 1.93 | 1.36 | 0.35 |
| ROIC %i | 10.15 | 1.73 | 4.41 | 4.72 | 4.83 | 3.45 | 3.36 | 2.09 |
| 5-year avg ROE %i | 7.57 | 6.00 | 8.40 | 8.23 | 8.22 | 5.39 | 5.90 | 4.80 |
| EBIT margin %i | 71.73 | 13.87 | 26.51 | 15.10 | 32.99 | 23.63 | 20.50 | 20.88 |
| FCF / sales %i | 45.96 | 42.36 | 46.11 | 41.94 | 43.68 | 43.84 | 39.64 | 44.36 |
| Current ratioi | 0.76 | 4.17 | 2.28 | 0.37 | 0.34 | 0.41 | 1.06 | 0.72 |
| Quick ratioi | 0.47 | 0.33 | 0.22 | 0.32 | 0.28 | 0.28 | 0.97 | 0.64 |
| Debt / assetsi | 43.78 | 43.86 | 40.69 | 41.78 | 42.52 | 45.12 | 45.26 | 49.88 |
| LT debt / equityi | 92.32 | 99.62 | 94.28 | 79.94 | 85.81 | 100.20 | 105.62 | 120.87 |
| Interest coveragei | 4.97 | 1.23 | 2.00 | 1.81 | 3.93 | 2.57 | 1.97 | 1.93 |
| Revenue CAGR (3Y) %i | -15.01 | -16.48 | -3.81 | 16.76 | 18.45 | 9.86 | 12.51 | 11.05 |
| Net income CAGR (3Y) %i | -- | -58.30 | -0.05 | -21.90 | 122.34 | -9.55 | -21.65 | -47.76 |
| FCF CAGR (3Y) %i | -11.45 | -11.34 | -3.62 | -2.15 | 2.09 | 8.03 | 10.41 | 11.62 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.26 | 1.97 | -0.48 | 0.89 | 2.77 | 3.08 |
| ROA %i | 1.38 | 0.82 | -0.20 | 0.35 | 1.07 | 1.17 |
| ROIC %i | 2.88 | 2.26 | 1.11 | 2.09 | 2.98 | 3.26 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.35 | 17.23 | 16.10 | 20.88 | 25.95 | 26.52 |
| FCF / sales %i | 42.81 | 44.52 | 44.32 | 44.36 | 42.94 | 41.73 |
| Current ratioi | 1.10 | 0.66 | 0.87 | 0.72 | 0.84 | 0.96 |
| Quick ratioi | 1.00 | 0.58 | 0.75 | 0.64 | 0.78 | 0.90 |
| Debt / assetsi | 46.34 | 47.20 | 48.17 | 49.88 | 49.56 | 47.60 |
| LT debt / equityi | 110.15 | 108.18 | 119.32 | 120.87 | 114.50 | 112.49 |
| Interest coveragei | 2.04 | 1.65 | 1.53 | 1.93 | 2.33 | 2.32 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Outpatient Medical is the largest reported line at 40.26% of revenue, across 5 reported segments.
- No single line clears half of revenue; Senior Housing is next at 28.05%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Outpatient Medical40.26%
Senior Housing28.05%
Lab28.01%
Interest income and other2.82%
Revenues for other non-reportable0.85%
Quote time 2026-10-08 07:27:45 · For reference only, not investment advice and not tailored to your situation.